Neuropace, Inc.

Q1 2026 13F Holders

Symbol
NPCE
CUSIP
641288105
Type
Equity
Class
COM
Num filings
115
Total reported value, excl. options
$348 M
Manager Report Date Value ($000) Shares Option Type